•
Mar 31, 2024

Nkgen Biotech Q1 2024 Earnings Report

Total Revenue
$0
EPS
-$0.25
Previous year: -$0.63
-60.3%
Gross Profit
-$326K
Cash and Equivalents
$284K
Previous year: $207K
+37.3%
Free Cash Flow
-$4.03M
Total Assets
$26.7M
Previous year: $176M
-84.8%

Nkgen Biotech

Nkgen Biotech